Lexi Webster
DMAA, or 1,3-dimethylamylamine, is a substance that has been banned in Australia since 2012 due to safety concerns. DMAA was commonly found in sports supplements and party pills as a stimulant to increase energy and enhance performance. However, it has been linked to adverse health effects, including high blood pressure, psychiatric disorders, bleeding in the brain, and even death. The decision to ban DMAA in Australia was made by the Therapeutic Goods Administration (TGA), which determined that the risks associated with DMAA use outweighed any potential benefits. This ban was implemented to protect public health and safety, and it is important for consumers to be aware of the potential dangers associated with this substance.
| Characteristics | Values |
|---|---|
| Date of ban | 8 August 2012 |
| Reasons for ban | DMAA is unsafe and has no accepted therapeutic use. It is a stimulant with psychoactive effects and has been linked to serious adverse health effects, including cardiac, nervous and psychiatric disorders, high blood pressure, bleeding in the brain, and stroke. |
| Regulatory body | Therapeutic Goods Administration (TGA) |
| Regulatory action | Banned the sale, supply, and use of DMAA, and included it in Appendix C of the Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP), which lists substances that are dangerous to health and prohibited from sale, supply, and use. |
| Enforcement | The TGA works with Australian Customs and Border Protection Services to stop shipments of products containing DMAA from entering Australia. |
Explore related products
What You'll Learn
DMAA's stimulant effects
DMAAs stimulant effects have been described as giving athletes an \"extra energy or an adrenaline-like high\". The substance increases heart rate and can cause vasoconstriction. DMAAs stimulant effects have been linked to several adverse health consequences, including high blood pressure, psychiatric disorders, bleeding in the brain, stroke, and even death.
DMAA was identified in the toxicology reports of two United States Army soldiers who died in 2011, and a New Zealand man who ingested 'party pills' containing DMAA suffered a cerebral hemorrhage. In 2010, nine Australian athletes tested positive for DMAA, which was at the time included in many sports supplements.
In June 2012, the Advisory Committee on Medicines Scheduling proposed including DMAA in Schedule 9 ('Prohibited Substances') of the Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP). The Therapeutic Goods Association (TGA) ultimately included DMAA in Appendix C of the SUSMP, noting that the substance has no accepted therapeutic use, and that a number of significant adverse events had been reported due to its use.
The stimulant effects of DMAA can include psychoactive effects, and the substance was actively promoted as a 'party drug' in addition to its use as a sports supplement. The TGA's decision to ban DMAA was based on the substance's potential lethal side effects and lack of therapeutic benefits.
Lyme Disease in Australia: What's the Risk?
You may want to see also
Explore related products
$9.15 $15.54
Safety concerns
DMAA, or 1,3-dimethylamylamine, is a substance that was previously included in many popular sports supplements. It is an ephedrine-like vasoconstricting substance that can have a stimulant effect, including psychoactive effects. Due to safety concerns, DMAA was banned in Australia in 2012 and included in Schedule 9 ('Prohibited Substances') of the Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP).
The decision to ban DMAA in Australia was made by the Therapeutic Goods Administration (TGA), following similar bans in several other countries, including New Zealand and the United States. The TGA concluded that DMAA has no accepted therapeutic use and that its use is unsafe, with potential adverse effects on human health, including cardiac, nervous, and psychiatric disorders. There have been reports of serious health consequences, such as high blood pressure, headaches, vomiting, stroke, and even death associated with DMAA use.
In addition to the health risks, DMAA was also actively promoted as a 'party drug', and there were concerns about its misuse as a sports supplement. It was included in many sports supplements and "party pills" to give athletes increased energy and an adrenaline-like high. The substance was found to increase heart rate and was linked to several deaths, including that of two United States Army soldiers in 2011 and two soldiers who collapsed during fitness training in the United States.
The ban on DMAA in Australia prohibits the sale, supply, and use of the substance. It is listed in Appendix C of the SUSMP, which includes substances that are dangerous to human health and are prohibited from being sold, supplied, or used. The TGA works closely with Australian Customs and Border Protection Services to prevent the entry of products containing DMAA into the country.
Trademark Laws: US vs. Australia - What's the Difference?
You may want to see also
Explore related products
DMAA's adverse effects
The sale, supply, and use of 1,4-Dimethylpentylamine (DMAA) are prohibited in Australia due to the dangers it poses to human health. DMAA is an ephedrine-like vasoconstricting substance that was previously included in many popular sports supplements. It has been associated with a range of adverse health effects, leading to its ban in the country.
One of the primary concerns regarding DMAA is its potential to cause cardiac, nervous, and psychiatric disorders. Users have reported experiencing high blood pressure, headaches, vomiting, and in severe cases, even stroke and death. The substance has also been linked to cerebral haemorrhage and has been implicated in the deaths of two United States Army soldiers in 2011.
DMAA was often marketed as a ''party drug' and a sports supplement, providing users with an adrenaline-like high and increased energy. Its stimulant effects can include psychoactive impacts, leading to escalated blood pressure and potential psychiatric issues. Additionally, DMAA has been associated with a decrease in body weight and body fat, indicating a potential impact on metabolic processes.
The Therapeutic Goods Administration (TGA) in Australia has played a crucial role in banning the substance. In June 2012, the Advisory Committee on Medicines Scheduling proposed including DMAA in Schedule 9 ('Prohibited Substances') of the Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP). Despite some opposition, the TGA ultimately recognized the health risks associated with DMAA and included it in Appendix C of the SUSMP, acknowledging its lack of accepted therapeutic use and the reported adverse events.
Australia's Smoking Ban in Pubs: A Historical Overview
You may want to see also
Explore related products
DMAA's vasoconstricting properties
DMAA, or 1,3-dimethylamylamine, is an ephedrine-like vasoconstricting substance. It was commonly included in many popular sports supplements and "party pills" before it was banned in Australia in 2012.
Several adverse events have been reported due to the use of DMAA, including cardiac, nervous, and psychiatric disorders. Specifically, DMAA has been linked to high blood pressure, headaches, vomiting, stroke, and even death. The substance increases heart rate and can induce an adrenaline-like high, which may have attracted athletes and bodybuilders seeking enhanced energy and performance.
The World Anti-Doping Agency (WADA) listed DMAA as a prohibited substance in 2010, and since then, several athletes from different countries have tested positive for its presence. The ban in Australia followed similar decisions made by other countries, including New Zealand, Canada, and the United States, where concerns about the substance's safety had already been raised.
While DMAA's vasoconstricting properties are a significant concern, there is a limited evidence base describing the full range of adverse effects and the specific dose thresholds at which these effects occur. The scheduling of DMAA as a prohibited substance may impede future research efforts to determine if there are any safe levels of consumption.
Sea Star Diet: Australian Edition
You may want to see also
Explore related products
DMAA's legality in other countries
DMAA, or 1,3-dimethylamylamine, is a stimulant similar to amphetamine that was originally developed in the 1940s as a nasal decongestant. In Australia, DMAA was banned in June 2012 after it was deemed unsafe for human consumption. This decision was made following bans in several other countries.
DMAA has also been prohibited in other countries, including:
- New Zealand: Banned in 2012 due in part to its growing recreational use as 'party pills'.
- Canada: Banned in 2011.
- United States: Illegal to market as a dietary supplement. In 2013, the FDA declared DMAA illegal for use as a dietary supplement ingredient.
- United Kingdom: In 2012, the MHRA ruled that DMAA-containing supplements were unlicensed medicinal products and needed to be removed from the market amid concerns about potential risks to public safety.
- Finland, Brazil, Sweden, Switzerland: These countries have also banned or heavily restricted the use of DMAA as a dietary supplement due to serious concerns about its safety.
The World Anti-Doping Agency (WADA) has listed DMAA as a prohibited substance since 2010, and athletes from several countries have tested positive for its presence.
Despite the bans and restrictions in many countries, DMAA continues to be produced and marketed in some places, and its legality remains a subject of debate.
Plexus Slim: Banned in Australia, Here's Why
You may want to see also
Frequently asked questions
DMAA, or 1,3-dimethylamylamine, is a stimulant that was previously included in many sports supplements. It was banned in Australia in 2012 due to safety concerns and the adverse health effects associated with its use. These effects include high blood pressure, psychiatric disorders, bleeding in the brain, and stroke.
DMAA is an ephedrine-like vasoconstricting substance, which means it can cause blood vessels to narrow. This can lead to increased blood pressure and other cardiovascular issues. There have also been reports of more severe consequences, including cerebral haemorrhage and death.
Yes, the Therapeutic Goods Administration (TGA) has identified certain products that contain DMAA, such as Plexus Slim Accelerator capsules and some sports supplements. The TGA advises consumers to exercise caution when purchasing medicines from unknown overseas websites as they may contain undisclosed and potentially harmful ingredients.
